Golech.Glob.Fin. (531360)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Small market cap of ₹15 Cr leaves room for a high-growth recovery if fundamentals improve
• Book value per share at ₹14.68 provides some theoretical asset backing, though price is nearly double
• Debt/Equity is N/A, which may indicate low reliance on borrowings
• 52-week range suggests the stock has active trading volatility, offering possible entry points for contrarians

Concerns

• Negative ROE of -16.99% and ROCE of -7.28% show poor capital allocation and operating inefficiency
• Sales growth of -59.29% and profit growth of -235.48% indicate a rapidly shrinking business
• Piotroski F-Score of 2/9 signals severe deterioration in financials
• No dividend yield and zero earnings make the stock reliant solely on speculative price appreciation

AI Analysis

When I look at Golech.Glob.Fin., the first thing that strikes me is the absence of earnings. A P/E of 0.00 means this company is losing money, and the numbers confirm it: ROE is -16.99%, ROCE is -7.28%, and profit growth has collapsed by 235.48%. Sales are down 59.29% from the prior year—this is not a temporary hiccup, it's a business in retreat. The latest quarter shows sales of just ₹2 crore and net profit essentially zero, so there's no sign of a turnaround brewing. As Graham would say, price is what you pay, value is what you get. Here, the market cap is ₹15 crore, but the book value is ₹14.68 per share, putting the price at 1.92 times book. That's no bargain for a company destroying shareholder value. With a Piotroski F-Score of 2 out of 9, the financial health is poor—this score screens for improving fundamentals, and this company fails almost every test. There is no dividend to compensate while we wait, and promoter holding isn't disclosed, so I can't even gauge insiders' skin in the game. The 52-week range shows the stock has halved from ₹38.20 to around ₹28, but that doesn't make it cheap; it makes it a falling knife. In the absence of a clear moat, pricing power, or a credible path back to profitability, this is the kind of speculative small-cap that value investors should avoid unless new management or a business overhaul emerges. I need evidence of stabilization first—not just a low price tag.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer